Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024Cancer MedicineOpen Access

Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

GLGuihong LiuXuzhou Medical CollegeTCTao ChenChinese PLA General HospitalXZXin ZhangXinjiang Normal University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liu et al. (2024) studied this question.

synapsesocial.com/papers/68e7649bb6db6435876da51bhttps://doi.org/10.1002/cam4.7075
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved Survival2005 · 518 citations
  2. 2The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer2019 · 16 citations
  3. 3Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-analysis.2022 · 39 citations
  4. 4Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial2018 · 1,020 citations